Petros Pharmaceuticals PTPI
OTC PTPI
$0.00 0.00 (-25.93%)
As of: Oct 21, 2026 · 12:22 PM EDT

Petros Pharmaceuticals, Inc. (PTPI) Capital Expenditures (2020 - 2024)

Updated

Petros Pharmaceuticals' Capital Expenditures came in at $5,449 for Q4 2024.

Analysis

Petros Pharmaceuticals, Inc. (PTPI) Capital Expenditures (2020 - 2024) Analysis & Trends

For FY2024, Petros Pharmaceuticals' Capital Expenditures was $24,587.

  • Capital Expenditures carries a four-year compound annual growth rate of 51.8% (FY2020 to FY2024).
  • Going back by year, Capital Expenditures was $4,633 in FY2020.
  • The Q4 2024 figure represents the lowest quarterly Capital Expenditures since Q3 2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5,449.00
Sep 30, 2020 204.00
Mar 31, 2020 4,429.00
API Access

Petros Pharmaceuticals, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PTPI&period=max&api_key=YOUR_API_KEY